CARLSBAD, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that
it plans to release its first quarter earnings results after market close on Tuesday, May 1, 2018. Management will hold a
conference call to review the Company's financial performance starting at 4:30 p.m. ET on the same day. The conference
call will be concurrently webcast. The link to the webcast will be available on the GenMark Diagnostics, Inc. website
at www.genmarkdx.com under the investor relations section and will be archived for future
reference. To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the
conference ID number 9384229 approximately five minutes prior to the start time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to
enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor®
detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic
tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True
Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing
needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.
Investor Relations Contact
Lynn Pieper Lewis or Leigh Salvo
(415) 937-5404
ir@genmarkdx.com
